MDT · Medtronic
AI read · Good for MDT
The AI's read
The added patient groups give doctors more evidence when weighing the system. That may support use, but doctors do not gain a broader approved use from this update.
Medtronic shared that its SPYRAL AFFIRM study showed big drops in blood pressure and got FDA approval for a new label.
Good for MDT
Medtronic reported blood pressure reductions, and nearly 9 in 10 patients showed clinical benefit. The approved use did not expand, but the added evidence may help doctors assess the system.
Get alerts for MDT
Follow Medtronic (MDT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MDTFree on the App Store and Google Play, or on the web.